1-20 of 106
Tomoki Naoe, MD.,PhD.
Close
Sort by
Journal Articles

Post-Treatment Clone Size Predicts Survival Independently of IPSS-R and Response after Azacitidine Therapy for MDS.

Yasuhito Nannya, MD PhD, Magnus Tobiasson, MD, Shinya Sato, MD, Elsa Bernard, PhD, Maria Creignou, Lanying Zhao, MD, PhD, June Takeda, MD, Yuichi Shiraishi, PhD, Kenichi Chiba, Hiroko Tanaka, Hisashi Tsurumi, MD PhD, Senji Kasahara, MD PhD, Masataka Taguchi, Akifumi Kondo Takaori, MD PhD, Kazuma Ohyashiki, MD PhD, Hideki Makishima, MD PhD, Kenichi Yoshida, MDPhD, Tomoki Naoe, MD PhD, Satoru Miyano, PhD, Yasushi Miyazaki, MD PhD, Elli Papaemmanuil, PhD, Eva Hellstrom Lindberg, MD PhD, Seishi Ogawa, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-139082
Published: 2020
Journal Articles

Nilotinib Vs. Dasatinib in Achieving MR 4.5 for Newly Diagnosed Chronic Myeloid Leukemia: Results of the Prospective Randomized Phase 3 Study, JALSG CML212

Itaru Matsumura, MDPhD, Shigeki Ohtake, MD PhD, Yoshiko Atsuta, MD PhD, Mio Kurata, Yosuke Minami, MDPhD, Naoto Takahashi, MD PhD, Chiaki Nakaseko, MDPhD, Noriyoshi Iriyama, MD PhD, Katsumichi Fujimaki, MD, Kazuhiko Kakihana, MD PhD, Yoji Ogasawara, Takaaki ONO, MD PhD, Masaya Okada, MD, Tetsuzo Tauchi, MD PhD, Toshihiro Miyamoto, MD PhD, Kazunori Ohnishi, MD, Emiko Sakaida, MDPhD, Shin Fujisawa, MD, Yukio Kobayashi, MDDSc, Norio Asou, MDPhD, Hitoshi Kiyoi, MD PhD, Yasushi Miyazaki, MD PhD, Tomoki Naoe, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-134168
Published: 2020
Journal Articles

Prognostic Effects of Pretreatment Statuses at Diagnosis in Patients with Chronic Myeloid Leukemia: Results of the New Target Observational Study 1

Takaaki ONO, MD PhD, Naoto Takahashi, MD PhD, Masahiro Kizaki, MD, Tatsuya Kawaguchi, MD, Ritsuro Suzuki, MD PhD, Kazuhito Yamamoto, Kazunori Ohnishi, MD, Tomoki Naoe, MD PhD, Itaru Matsumura, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4149.
https://doi.org/10.1182/blood-2019-122092
Published: 2019
Journal Articles

Prospective Comparison of Azacitidine Treatment between 7-Days and 5-Days Schedules for Patients with Higher-Risk Myelodysplastic Syndromes; Results of Japan Adult Leukemia Study Group MDS212 Trial

Toru Kiguchi, MD PhD, Shinya Sato, MD, Kensuke Usuki, MD PhD, Ken Ishiyama, Yoshikazu Ito, MD PhD, Takahiro Suzuki, MD PhD, Jun Taguchi, MD PhD, Shigeru Chiba, MD PhD, Nobuaki Dobashi, MD, Akihiro Tomita, MD PhD, Hironori Harada, MD PhD, Hiroshi Handa, MD PhD, Shigeo Horiike, MD PhD, Tomoya Maeda, MD PhD, Mitsuhiro Matsuda, MD PhD, Motoshi Ichikawa, MD, Tomoko Hata, MD, PhD, Sumihisa Honda, Satoshi Iyama, MD PhD, Hitoshi Suzushima, MD PhD, Yukiyoshi Moriuchi, MD, Toshiro Kurokawa, MD PhD, Takahiro Yamauchi, MD PhD, Hitoshi Kiyoi, MD PhD, Tomoki Naoe, MD PhD, Yasushi Miyazaki, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 845.
https://doi.org/10.1182/blood-2019-122802
Published: 2019
Journal Articles

Prospective Evaluation of Allogeneic HSCT at the First Remission for Younger Adults with FLT3 -ITD Positive Acute Myeloid Leukemia: The JALSG AML209-FLT3-SCT Study

Naomi Kawashima, MD PhD, Yuichi Ishikawa, MD PhD, Yoshiko Atsuta, MD PhD, Masashi Sawa, MD PhD, Yukiyasu Ozawa, MD PhD, Masaki Hayashi, MD, Akio Kohno, MD PhD, Akihiro Tomita, MD PhD, Tomoya Maeda, MD PhD, Emiko Sakaida, MD PhD, Kensuke Usuki, MD PhD, Maki Hagihara, MD PhD, Heiwa Kanamori, MD PhD, Hiroshi Matsuoka, MD PhD, Miki Kobayashi, MD PhD, Norio Asou, MD PhD, Shigeki Ohtake, MD PhD, Itaru Matsumura, MD PhD, Yasushi Miyazaki, MD PhD, Tomoki Naoe, MD PhD, Hitoshi Kiyoi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1328.
https://doi.org/10.1182/blood-2019-124394
Published: 2019
Journal Articles

Second-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia with Additional Chromosomal Abnormalities

Naoto Takahashi, MD PhD, Tomoko Yoshioka, MD, Masahiro Kizaki, MD, Tatsuya Kawaguchi, MD, Ritsuro Suzuki, MD PhD, Kazuhito Yamamoto, Kazunori Ohnishi, MD, Tomoki Naoe, MD PhD, Itaru Matsumura, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1640.
https://doi.org/10.1182/blood-2019-123337
Published: 2019
Journal Articles

Molecular Characteristics That Predict Response to Azacitidine Therapy

Yasuhito Nannya, MD PhD, Magnus Tobiasson, MD PhD, Elsa Bernard, PhD, Shinya Sato, MD, Maria Creignou, June Takeda, MD, Lanying Zhao, MD, PhD, Yuichi Shiraishi, PhD, Kenichi Chiba, PhD, Hiroko Tanaka, BA, Hisashi Tsurumi, MD PhD, Senji Kasahara, MD PhD, Masataka Taguchi, Akifumi Kondo Takaori, MD PhD, Kazuma Ohyashiki, MD PhD, Hideki Makishima, MD PhD, Kenichi Yoshida, MD PhD, Tomoki Naoe, MD PhD, Yasushi Miyazaki, MD PhD, Satoru Miyano, PhD, Elli Papaemmanuil, PhD, Eva Hellstrom Lindberg, MD PhD, Seishi Ogawa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4246.
https://doi.org/10.1182/blood-2019-129420
Published: 2019
Journal Articles

Prospective Evaluation of Prognostic Relevance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: Results from the JALSG CBF-AML209-KIT Study

Naomi Kawashima, MD, Yuichi Ishikawa, MD PhD, Yoshiko Atsuta, MD PhD, Isamu Sugiura, MD, Masashi Sawa, MD PhD, Nobuaki Dobashi, MD, Hisayuki Yokoyama, MD PhD, Noriko Doki, MD PhD, Akihiro Tomita, MD PhD, Toru Kiguchi, MD PhD, Shiro Koh, MD, Heiwa Kanamori, MD PhD, Noriyoshi Iriyama, MD PhD, Akio Kohno, MD, Yukiyoshi Moriuchi, MD, Noboru Asada, MD PhD, Daiki Hirano, MD, Kazuto Togitani, MD, Toru Sakura, PhD MD, Maki Hagihara, MD PhD, Tatsuki Tomikawa, MD PhD, Yasuhisa Yokoyama, MDPhD, Norio Asou, MDPhD, Shigeki Ohtake, MD PhD, Itaru Matsumura, MD, Yasushi Miyazaki, MD PhD, Tomoki Naoe, MD PhD, Hitoshi Kiyoi, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 438.
https://doi.org/10.1182/blood-2018-99-113931
Published: 2018
Journal Articles

Analysis of Genomic Predispositions to Sporadic Myeloid Neoplasms Mediated By DDX41 in Japan

June Takeda, MD, Kenichi Yoshida, MD PhD, Tetsuichi Yoshizato, MD PhD, Yuichi Shiraishi, PhD, Yusuke Okuno, MD PhD, Ayana Kon, MD PhD, Keisuke Kataoka, MD PhD, Kenichi Chiba, PhD, Hiroko Tanaka, BA, Masashi Sanada, MD PhD, Ken Ishiyama, MD PhD, Shigeru Chiba, MD PhD, Norio Asou, MD PhD, Yasushi Miyazaki, MD PhD, Tomoki Naoe, MD PhD, Kensuke Usuki, MD PhD, Shuichi Miyawaki, MD PhD, Yoichiro Kamatani, MD PhD, Yukihide Momozawa, DVM, PhD, Masao Nagasaki, PhD, Satoru Miyano, PhD, Michiaki Kubo, MD PhD, Hideki Makishima, MD PhD, Seishi Ogawa, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4371.
https://doi.org/10.1182/blood-2018-99-117664
Published: 2018
Journal Articles

ZNF384-Fusion Proteins Have High Affinity to EP300, Which Increases Their Transcriptional Activities

Hideyuki Yamamoto, MD, Fumihiko Hayakawa, MD, PhD, Takahiko Yasuda, MD, PhD, Yuka Minamikawa, Naoyuki Tange, MD, Daiki Hirano, MD, Yuki Kojima, MD, PhD, Takanobu Morishita, MD, PhD, Shinobu Tsuzuki, MD, PhD, Hiroyuki Mano, MD,PhD, Tomoki Naoe, MD PhD, Hitoshi Kiyoi, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1554.
https://doi.org/10.1182/blood-2018-99-114414
Published: 2018
Journal Articles

Efficacy and Safety of Tyrosine Kinase Inhibitors for Treatment of Newly Diagnosed Chronic Myeloid Leukemia: Results Using Data Obtained with the New Target System from the Japanese Registry

Naoto Takahashi, MD, Masahiro Kizaki, MDPhD, Masatomo Miura, PhD, Tatsuya Kawaguchi, MD PhD, Ritsuro Suzuki, MD PhD, Kazuhito Yamamoto, MDPhD, Kazunori Ohnishi, MD PhD, Itaru Matsumura, MD, Tomoki Naoe, MD PhD, Koichi Akashi, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1751.
https://doi.org/10.1182/blood-2018-99-111680
Published: 2018
Journal Articles

CD56 Is an Unfavorable Prognostic Factor for Acute Promyelocytic Leukemia: Results By Multivariate Analyses in the JALSG-APL204 Study

Akihiro Takeshita, MDPhD, Norio Asou, MD PhD, Yoshiko Atsuta, MD PhD, Hiroaki Furumaki, MD, Toru Sakura, PhD MD, Yasunori Ueda, MD PhD, Masashi Sawa, MD PhD, Nobuaki Dobashi, MD, Rikio Suzuki, MD PhD, Yasuhiro Taniguchi, MD, Masaru Nakagawa, MD PhD, Shigehisa Tamaki, MD, Maki Hagihara, MD PhD, Katsumichi Fujimaki, MD, Yasuhisa Yokoyama, MD PhD, Hiroyuki Fujita, MD PhD, Masamitsu Yanada, MD PhD, Yoshinobu Maeda, MD PhD, Noriko Usui, MD PhD, Yukio Kobayashi, MD DSc, Hitoshi Kiyoi, MD PhD, Shigeki Ohtake, MD PhD, Itaru Matsumura, MD, Tomoki Naoe, MD PhD, Yasushi Miyazaki, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2798.
https://doi.org/10.1182/blood-2018-99-111638
Published: 2018
Journal Articles

Phase II Trial of a Peptide Vaccine, Ocv-501 in Elderly Patients with Acute Myeloid Leukemia

Masaki Yamaguchi, MD PhD, Naoki Takezako, MD PhD, Toru Kiguchi, MD PhD, Shuichi Miyawaki, MD PhD, Yuji Heike, MD PhD, Kaori Mitsuki, Takahiro Yoshida, PhD, Ei Leen Liew, PhD MS, Tomoki Naoe, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 29.
https://doi.org/10.1182/blood-2018-99-110013
Published: 2018
Journal Articles

Genomic and Clinical Characterization of Adult Ph-Negative B-Cell Acute Lymphoblastic Leukemia

Takahiko Yasuda, MD, PhD, Dai Nishijima, PhD, Shinya Kojima, PhD, Masahito Kawazu, MD, PhD, Toshihide Ueno, PhD, Shinobu Tsuzuki, MD PhD, Hitoshi Kiyoi, MD PhD, Itaru Matsumura, MD, Yasushi Miyazaki, MD PhD, Keizo Horibe, MD PhD, Hiroyuki Mano, MD, PhD, Tomoki Naoe, MD PhD, Masashi Sanada, MD PhD, Fumihiko Hayakawa, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2821.
https://doi.org/10.1182/blood-2018-99-115716
Published: 2018
Journal Articles

Combining the Number of Infectious Episodes and Interval of Chemotherapy to Transplantation May Predict a Transplant Outcome in Patients with Acute Myeloid Leukemia: A Retrospective Analysis of JALSG AML201 Study

Satoshi Kaito, MD, Noriko Doki, MD PhD, Yuho Najima, MD, Shigeki Ohtake, MD PhD, Hitoshi Kiyoi, MD PhD, Hiroyuki Fujita, MD PhD, Yasushi Miyazaki, MD PhD, Noriko Usui, MD PhD, Hirokazu Okumura, MD PhD, Koichi Miyamura, MD PhD, Emiko Sakaida, MD PhD, Atsushi Fujieda, MD PhD, Nagai Tadashi, MD PhD, Takahisa Yamane, MD PhD, Ohnishi Kazunori, MD PhD, Tomoki Naoe, MD PhD, Kazuteru Ohashi, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4643.
https://doi.org/10.1182/blood-2018-99-114565
Published: 2018
Journal Articles

High Expression of MEF2D-Fusion Protein Is Caused By Escaping from the Suppression By miRNA and Leads to Suppress Transcriptional Activity of PAX5

Hirano Daiki, MD, Fumihiko Hayakawa, MD PhD, Takahiko Yasuda, MDPhD, Naoyuki Tange, MD, Hideyuki Yamamoto, MD, Yuki Kojima, MD PhD, Takanobu Morishita, MD PhD, Naoto Imoto, MD PhD, Shinobu Tsuzuki, MDPhD, Hiroyuki Mano, MDPhD, Tomoki Naoe, MD PhD, Hitoshi Kiyoi, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3977.
https://doi.org/10.1182/blood.V130.Suppl_1.3977.3977
Published: 2017
Journal Articles

Tamibarotene As Maintenance Therapy for Acute Promyelocytic Leukemia Improved Long Term Relapse-Free Survival: 7-Year Results from a Randomized Controlled Trial, JALSG-APL204

Akihiro Takeshita, MDPhD, Norio Asou, MD, Masamitsu Yanada, MD PhD, Toru Sakura, PhD MD, Yasunori Ueda, MD PhD, Masashi Sawa, MD, Nobuaki Dobashi, MD, Makoto Onizuka, MD PhD, Yasuhiro Taniguchi, MD, Masaru Nakagawa, MD PhD, Shigehisa Tamaki, Maki Hagihara, MD PhD, Katsumichi Fujimaki, MD PhD, Hiroaki Furumaki, MD, Hiroyuki Fujita, MD PhD, Noriko Usui, MD, Yukio Kobayashi, MD PhD, Hitoshi Kiyoi, MD PhD, Shigeki Ohtake, MD, Yoshiko Atsuta, MD PhD, Itaru Matsumura, MDPhD, Tomoki Naoe, MD PhD, Yasushi Miyazaki, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 642.
https://doi.org/10.1182/blood.V130.Suppl_1.642.642
Published: 2017
Journal Articles

Residual Blast Cells in Bone Marrow on Day 15 Following Remission Induction Therapy for Acute Myeloid Leukemia Is Associated with Long-Term Prognosis: A Retrospective Analysis of the JALSG AML201 Study

Maki Hagihara, MD PhD, Shin Fujisawa, MD PhD, Sumihisa Honda, PhD, Shigeki Ohtake, MD PhD, Shuichi Miyawaki, MD PhD, Nobuaki Dobashi, MD, Toru Sakura, MD, Yukiyasu Ozawa, MD PhD, Yoshikazu Ito, MD PhD, Katsumichi Fujimaki, MD PhD, Asao Hirose, MD PhD, Hiroyuki Fujita, MD PhD, Kinya Ohata, MD PhD, Tomoya Maeda, MD PhD, Toshi Imai, MD, Hitoshi Kiyoi, MD PhD, Yasushi Miyazaki, MD PhD, Kazunori Ohnishi, MD PhD, Tomoki Naoe, MD PhD, Hideaki Nakajima, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2795.
https://doi.org/10.1182/blood.V128.22.2795.2795
Published: 2016
Journal Articles

Intrabone Transplantation of a Single Cord Blood Unit Using Non-Irradiated Reduced-Intensity Conditioning

Makoto Murata, MD PhD, Yoshinobu Maeda, MD PhD, Masayoshi Masuko, MD PhD, Yasushi Onishi, MD PhD, Tomoyuki Endo, MD PhD, Seitaro Terakura, MD PhD, Yuichi Ishikawa, MD PhD, Chisako Iriyama, MD PhD, Yoko Ushijima, MD PhD, Tatsunori Goto, MD, Nobuharu Fujii, MD PhD, Mitsune Tanimoto, MD PhD, Hironori Kobayashi, MD PhD, Yasuhiko Shibasaki, MD PhD, Noriko Fukuhara, MD PhD, Yoshihiro Inamoto, MD PhD, Ritsuro Suzuki, MD PhD, Tadashi Matsushita, Yoshihisa Kodera, MD PhD, Hitoshi Kiyoi, MD PhD, Tomoki Naoe, MD PhD, Tetsuya Nishida, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3390.
https://doi.org/10.1182/blood.V128.22.3390.3390
Published: 2016
Journal Articles

Preliminary Results from a Phase 1/2 Study of DSP-7888, a Novel WT1 Peptide-Based Vaccine, in Patients with Myelodysplastic Syndrome (MDS)

Shigesaburo Miyakoshi, MD PhD, Kensuke Usuki, MD PhD, Itaru Matsumura, MD PhD, Yasunori Ueda, MD PhD, Hiromi Iwasaki, MD PhD, Toshihiro Miyamoto, MD PhD, Makoto Origuchi, Shuzo Tagashira, Ichiro Naoi, Tomoki Naoe, MD PhD, Masahiro Kizaki, MD PhD, Yuji Heike, MD PhD, Koichi Akashi, MD PhD, Yasushi Miyazaki, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4335.
https://doi.org/10.1182/blood.V128.22.4335.4335
Published: 2016